• The Effectiveness of Patient Navigation in Cancer Care

  NCT03305965

  Unknown statusInterventionalNot ApplicableUpdated Oct 10, 2017
• Nurse Navigation Versus Current Care Coordination During Colorectal Cancer Trajectories

  NCT03281447

  CompletedInterventionalNot ApplicableUpdated Apr 4, 2019
• A Lay Navigation Intervention for Patients With Lung Cancer

  NCT07548788

  Not yet recruitingInterventionalNot ApplicableUpdated Apr 23, 2026
• The Effect of Nurse Navigation Program on Lung Cancer Patients

  NCT05937425

  CompletedInterventionalNot ApplicableUpdated Jan 29, 2025
• A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical Care

  NCT05488444

  WithdrawnInterventionalPhase 2Updated Oct 22, 2024
• A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer Survivors

  NCT07699991

  RecruitingInterventionalNot ApplicableUpdated Aug 14, 2026

ClinicalTrials.gov ID

NCT05053997

Lead Sponsor

Zealand University HospitalOTHER

Overall Status

Recruiting

Study Type

Interventional

Phase

Not Applicable

Enrollment

250Estimated

Last Update Posted

Dec 29, 2025Actual

Start Date

Mar 1, 2022Actual

Primary Completion Date

Dec 31, 2026Estimated

Completion Date

Dec 31, 2026Estimated

Official Title

NAVIGATE - Improving Survival and Quality of Life in Vulnerable Lung Cancer Patients Through Nurse Navigation, Symptom Monitoring and Exercise: Study Protocol for a Multicenter Randomized Controlled Trial

Brief Summary

Half of patients with lung cancer face a limited life span of one-year survival, which is characterized by severe physical and psychological symptoms. Differences in stage, comorbidity but also treatment may explain a large proportion of the social inequality in lung cancer survival. Some vulnerable patients may not receive first line treatment as planned either due to poor performance status or if they are not able to adhere to treatment appointments. Knowing how to navigate the health system may be a barrier preventing vulnerable patients in receiving optimal treatment. The primary aim of this randomised, controlled trial is to test whether a nurse-led individually tailored program including systematic screening of symptoms using PROs and a physical training program will significantly improve a composite outcome of survival and quality of life as the primary outcome among vulnerable lung cancer patients compared with standard care. Secondary outcomes include adherence to cancer treatment, symptom burden and overall survival.

Detailed Description

During a period of 3 years and 10 months, consecutive newly diagnosed (< 1 week) lung cancer patients will be pre-screened for eligibility and invited to participate at departments of oncology or respiratory medicine in Denmark. Participants (N=250) will be randomized (1:1) to standard treatment plus the intervention (intervention group) or standard treatment (control group) and followed for 1 year. Patients randomized to the control group will receive standard treatment and care consisting of a nurse and a physician, who sees the patient at treatment schedules and during follow-up, i.e. every 3 months for the first 2 years and subsequently annually up to 5 years.

Data will be collected from the intervention and the control group at baseline within 6 weeks after diagnosis, and 3, 6 months and 12 months after diagnosis. Physical tests will be performed at baseline and after 3 and 6 months. Baseline physical tests will be allowed after randomization if patients have difficulties in attending the physiotherapy department within 6 weeks after their diagnosis. Considering that participating patients are vulnerable with limited resources we will proactively support patients in responding to questionnaires electronically, on paper or via telephone as per patient's preference allowing evaluation of the primary and secondary outcomes as well as covariates and mechanisms. The treatment factors will be obtained from the lung cancer clinical database and individual medical journals. In order to develop cost utility analyses, information on use of health services will be retrieved from the national registers.

• Lung Cancer

• NAVIGATE

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• Age ≥ 18 years of age
• Diagnosed with NSCLC at all stages regardless of treatment intension at the participating departments
• Performance status ≤ 2
• Vulnerable according to pre-defined criteria

Exclusion Criteria:

• Severe untreated psychiatric disorder (e.g. psychosis) or cognitive problems (e.g. dementia) preventing informed consent
• Not able to receive treatment
• Not able to read and understand Danish -

Primary Purpose

Treatment

Allocation

Randomized

Interventional Model

Parallel Assignment

Masking

None (Open Label)

Lead Sponsor

Zealand University HospitalOTHER

Collaborators

Danish Cancer SocietyOTHER

Odense University HospitalOTHER

Vejle HospitalOTHER

Hospital of Southern JutlandOTHER

Ole.Hilberg@rsyd.dk